
|
Channels
|
||||||||||||||||||||
|
Medical Health Encyclopedia
Hypothyroidism - primary
From Healthscout's partner site on diet and exercise, HealthCentral.com
The purpose of treatment is to replace the thyroid hormone that is lacking. Levothyroxine (T4) is the most commonly used medication. However a form of T3 is sometimes used together with thyroxine. A combination of T4 and T3 is also available. Most people feel their best when TSH level is brought into the 1 - 2 mcIU/mL range. People get the lowest dose that effectively relieves their symptoms and brings their blood tests into the normal range. Life-long therapy is needed. The condition will come back if therapy is interrupted. You must keep taking your medication even when your symptoms go away. ![]() After you start taking replacement therapy, tell you doctor about any symptoms of increased thyroid activity (hyperthyroidism), such as:
Myxedema coma is treated with intravenous thyroid replacement and steroid medications. Some people may need supportive therapy (oxygen, breathing assistance, and fluid replacement). Support Groups Expectations (prognosis) With early treatment, the condition can be completely controlled. However, the condition will return if you do not continue to take your medication. Myxedema coma can result in death. Complications Myxedema coma, the most severe form of hypothyroidism, is rare. It may be caused by:
Symptoms and signs of myxedema coma include:
Other complications include:
Complications that can occur with too much thyroid hormone replacement include:
Calling your health care provider Call your health care provider if you have symptoms of hypothyroidism or myxedema. Also call if you experience these symptoms after beginning thyroid replacement therapy:
Review Date: 06/17/2008 A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). ![]() | ||||||||||||||||||||
|
Search
Health Tools
Featured Conditions
Resources
Find a Therapist
PR Newswire
|
New Features
|
|||||||||||||||||||
|
||||||||||||||||||||